Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Altacor Ltd.

www.altacor-pharma.com

Latest From Altacor Ltd.

Upsher-Smith To Buy U.K. Biotech Partner Proximagen For $347 Million

Proposed acquisition mimics other recent M&A deals, like Sanofi/Genzyme, with inclusion of contingent-value rights pegged to success of two clinical candidates.

BioPharmaceutical United States

Deals Shaping The Medical Industry, April 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

In Brief

Valeant buys into Russian OTC market; NicOx buys stake in U.K. ophthalmology firm Altacor; Naturex reaches India coverage; Eurofins purchases BASF test business; Fortitech fortifies Asian presence; more news In Brief.

Consumer Asia Pacific

Deals Of The Week: Shire/Heptares, NicOx/Altacor, UCB/Oxford University

This past week saw two GPCR-focused deals – Shire’s optioning of a preclinical adenosine A2a antagonist and Anaphore’s acquisition of a platform company specializing in biologics targeting GPCRs.

Europe Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Altacor Ltd.
  • Senior Management
  • Fran Crawford, CEO
    Rob Sprawson, CFO
    David Alcraft, Dir., Bus. Dev.
    Andy Baxter, Head, Product Development
    Gareth Thomas, Head, Sales & Mktg.
  • Contact Info
  • Altacor Ltd.
    Phone: (44) 1223 421 411
    St. John's Innovation Centre
    Crowley Rd.
    Cambridge, CB40WS
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register